For example, α‐synuclein of Parkinson's disease co‐aggregates with amylin in pancreatic β‐cell amyloid formation in T2D, and amylin‐tau cross‐seeding has been implicated in driving toxic tau pathology, raising the risk among individuals with T2D for AD.69, 70. This evidence concerns the gene IAPP and Parkinson disease.